Join
Live feed
·
PRReleasevia Quantisnow
4D Molecular Therapeutics Inc. logo

4DMT Reports First Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FDMT (4D Molecular Therapeutics Inc.) and more on Quantisnow.